Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
about
Estimation of human blood plasma 5-hydroxyindoleacetic acid and homovanillic acid.An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine.Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamineKhat use and appetite: an overview and comparison of amphetamine, khat and cathinone.Critical role of the embryonic mid-hindbrain organizer in the behavioral response to amphetamine and methylphenidate.Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic alpha-adrenoceptors.Effects of drugs acting on cerebral 5-hydroxytryptamine mechanisms on dopamine-dependent turning behaviour in mice.Pimozide and p-chlorophenylalanine blockade in DL-amphetamine and pargyline-treated rats held at two environmental temperatures.Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacologic agents in adult and developing rats.Interactions of various drugs with amphetamine.The "spastic colon" syndrome: therapeutic and pathophysiologic considerations.Effects of captivity on glucose tolerance in dogs.Carvacrol: from ancient flavoring to neuromodulatory agent.Regional neurochemical studies on the effect of beta, beta'-iminodipropionitrile (IDPN) in the rat.Amphetamine analogs have differential effects on DRL 36-s schedule performance.Tph2 gene deletion enhances amphetamine-induced hypermotility: effect of 5-HT restoration and role of striatal noradrenaline release.
P2860
Q33260241-2AF2E420-DD1F-455C-9996-17FCE0D5A0C2Q34035836-F576A15A-19FB-43BD-9A88-C1380E0ECE50Q34692213-3CDE25E5-4A04-4FD8-880C-89A3D978C412Q34797774-D4DEB447-8213-4FE3-86CF-FFB135F6F3C3Q37439849-6D3A60D2-704A-4A03-913B-F1565422885CQ39132003-5ED5BF39-076B-4A5E-86DA-52EE9CB9B5DBQ39442966-729EFAB5-ED78-4015-B090-743E9D2D4C91Q39761971-4C435218-BC9D-4D99-B260-912BEA7A5160Q39896201-A9268ED7-BBF0-4C11-9599-9A08E3C81E7BQ40014537-0706BA46-D851-4E81-9568-0531AFBE47C5Q40560668-403555B7-7F2A-4D59-95A2-E43CAF281066Q40646550-CF7DA25C-A7B6-42E5-B40F-1061825E780DQ40789344-37F940AF-A56F-4CFD-B0D8-915F5134D479Q44401192-1D08E548-C63B-4A6E-9B6E-A95C41FCF670Q46524353-A1C2F9CD-42B1-48AE-82B8-1F3ED6BD918AQ48481117-12E4CFA2-3119-40C6-81E2-D6396271D967Q52206235-53F3E8F6-4121-4264-AC08-9A357BD728F2Q52307553-4D7CC1F9-2BAC-45C7-9CBD-CE03473BA766
P2860
Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh-hant
name
Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
@en
Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
@nl
type
label
Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
@en
Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
@nl
prefLabel
Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
@en
Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
@nl
P2093
P2860
P1476
Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1974.TB09714.X
P407
P577
1974-10-01T00:00:00Z